Gainers
- Motus GI Hldgs (NASDAQ:MOTS) shares increased by 62.3% to $0.42 during Tuesday's after-market session. At the close, Motus GI Hldgs's trading volume reached 3.6 million shares. This is 683.5% of its average volume over the last 100 days. The company's market cap stands at $23.0 million.
- Genocea Biosciences (NASDAQ:GNCA) shares rose 14.94% to $0.07. Genocea Biosciences's trading volume hit 8.9 million shares by close, accounting for 393.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.1 million.
- Esperion Therapeutics (NASDAQ:ESPR) shares moved upwards by 9.49% to $6.34. The company's market cap stands at $399.4 million.
- 180 Life Sciences (NASDAQ:ATNF) shares increased by 8.87% to $1.35. The company's market cap stands at $46.0 million.
- OpGen (NASDAQ:OPGN) stock moved upwards by 7.58% to $0.39. The company's market cap stands at $18.1 million.
- Ardelyx (NASDAQ:ARDX) shares moved upwards by 6.99% to $0.64. The company's market cap stands at $92.0 million.
Losers
- Verrica Pharmaceuticals (NASDAQ:VRCA) shares fell 36.9% to $3.51 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 99.4K shares, which is 89.9 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $96.5 million.
- Better Therapeutics (NASDAQ:BTTX) shares decreased by 9.14% to $1.99. Trading volume for this security closed at 2.6 million, accounting for 47.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $46.9 million.
- Chinook Therapeutics (NASDAQ:KDNY) stock declined by 7.28% to $14.01. The company's market cap stands at $773.0 million.
- Vallon Pharmaceuticals (NASDAQ:VLON) shares fell 6.91% to $0.48. The market value of their outstanding shares is at $5.0 million.
- HTG Molecular Diagnostics (NASDAQ:HTGM) stock decreased by 5.94% to $0.56. HTG Molecular Diagnostics's trading volume hit 955.4K shares by close, accounting for 150.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.7 million.
- Titan Pharmaceuticals (NASDAQ:TTNP) stock fell 5.2% to $0.36. The company's market cap stands at $4.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
